Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enoxaparin vs Unfractionated Heparin in STEMI (ExTRACT-TIMI 25)
NCT00077792Phase 3Completed
- Sponsor
- Sanofi
- Start
- Oct 2002
- Primary completion
- Dec 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 48
01
Overview
A Phase 3 trial of enoxaparin in ST-segment elevation myocardial infarction (STEMI), sponsored by Sanofi. Started Oct 2002; status: completed.
02
Drugs
enoxaparin
03
Conditions
ST-segment elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT00077792.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00077792.